These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 30216512)

  • 1. Knockdown of RPL34 inhibits the proliferation and migration of glioma cells through the inactivation of JAK/STAT3 signaling pathway.
    Ji P; Wang L; Liu J; Mao P; Li R; Jiang H; Lou M; Xu M; Yu X
    J Cell Biochem; 2019 Mar; 120(3):3259-3267. PubMed ID: 30216512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Silencing of Ribosomal Protein L34 (RPL34) Inhibits the Proliferation and Invasion of Esophageal Cancer Cells.
    Fan H; Li J; Jia Y; Wu J; Yuan L; Li M; Wei J; Xu B
    Oncol Res; 2017 Aug; 25(7):1061-1068. PubMed ID: 28109079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Artificial Downregulation of Ribosomal Protein L34 Restricts the Proliferation and Metastasis of Colorectal Cancer by Suppressing the
    Liang YC; Li R; Bao SR; Li ZL; Yin HZ; Dai CL
    Hum Gene Ther; 2023 Aug; 34(15-16):719-731. PubMed ID: 37427415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ribosomal protein L34 promotes the proliferation, invasion and metastasis of pancreatic cancer cells.
    Wei F; Ding L; Wei Z; Zhang Y; Li Y; Qinghua L; Ma Y; Guo L; Lv G; Liu Y
    Oncotarget; 2016 Dec; 7(51):85259-85272. PubMed ID: 27845896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of ALK4 inhibits cell proliferation and migration through the inactivation of JAK/STAT3 signaling pathway in glioma.
    Song C; Fan B; Xiao Z
    Biomed Pharmacother; 2018 Feb; 98():440-445. PubMed ID: 29278854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RPL34-Divergent Transcript, a Novel Long NonCoding Ribonucleic Acid, Promotes Migration by Activating Epithelial-Mesenchymal Transition in Glioma.
    Lu X; Zhang D
    World Neurosurg; 2023 Nov; 179():e582-e592. PubMed ID: 37689361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Highly expressed ribosomal protein L34 indicates poor prognosis in osteosarcoma and its knockdown suppresses osteosarcoma proliferation probably through translational control.
    Luo S; Zhao J; Fowdur M; Wang K; Jiang T; He M
    Sci Rep; 2016 Nov; 6():37690. PubMed ID: 27883047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of RPL34 Inhibits Tumor Cell Proliferation and Promotes Apoptosis in Glioblastoma.
    Du C; Wang T; Jia J; Li J; Xiao Y; Wang J; Mao P; Wang N; Shi L; Wang M
    Appl Biochem Biotechnol; 2022 Aug; 194(8):3494-3506. PubMed ID: 35377127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Over-expressed RPL34 promotes malignant proliferation of non-small cell lung cancer cells.
    Yang S; Cui J; Yang Y; Liu Z; Yan H; Tang C; Wang H; Qin H; Li X; Li J; Wang W; Huang Y; Gao H
    Gene; 2016 Jan; 576(1 Pt 3):421-8. PubMed ID: 26526135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RPL34-AS1-induced RPL34 inhibits cervical cancer cell tumorigenesis via the MDM2-P53 pathway.
    Zhu Y; Ren C; Jiang D; Yang L; Chen Y; Li F; Wang B; Zhang Y
    Cancer Sci; 2021 May; 112(5):1811-1821. PubMed ID: 33675124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNAi-mediated RPL34 knockdown suppresses the growth of human gastric cancer cells.
    Liu H; Liang S; Yang X; Ji Z; Zhao W; Ye X; Rui J
    Oncol Rep; 2015 Nov; 34(5):2267-72. PubMed ID: 26323242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RPL34-AS1 functions as tumor suppressive lncRNA in esophageal cancer.
    Gong Z; Li J; Cang P; Jiang H; Liang J; Hou Y
    Biomed Pharmacother; 2019 Dec; 120():109440. PubMed ID: 31574377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of the RPL34 gene on the growth and metastasis of oral squamous cell carcinoma cells.
    Dai J; Wei W
    Arch Oral Biol; 2017 Nov; 83():40-46. PubMed ID: 28697409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knockdown of TRIM37 suppresses the proliferation, migration and invasion of glioma cells through the inactivation of PI3K/Akt signaling pathway.
    Tang SL; Gao YL; Wen-Zhong H
    Biomed Pharmacother; 2018 Mar; 99():59-64. PubMed ID: 29324313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rap2B promotes cell adhesion, proliferation, migration and invasion of human glioma.
    Miao F; Cui C; Zuo D; Zhang H; Mei P; Chen H; Wei S; Yang F; Zheng J; Bai J; Fan Y
    J Neurooncol; 2019 Jun; 143(2):221-229. PubMed ID: 30997639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ELTD1 facilitates glioma proliferation, migration and invasion by activating JAK/STAT3/HIF-1α signaling axis.
    Li J; Shen J; Wang Z; Xu H; Wang Q; Chai S; Fu P; Huang T; Anas O; Zhao H; Li J; Xiong N
    Sci Rep; 2019 Sep; 9(1):13904. PubMed ID: 31554859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNA-binding Protein UNR Promotes Glioma Cell Migration and Regulates the Expression of Ribosomal Protein L9.
    Tian NY; Qi YJ; Hu Y; Yin B; Yuan JG; Qiang BQ; Peng XZ; Han W
    Chin Med Sci J; 2018 Sep; 33(3):143-151. PubMed ID: 30266104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long noncoding RNA papillary thyroid carcinoma susceptibility candidate 3 (PTCSC3) inhibits proliferation and invasion of glioma cells by suppressing the Wnt/β-catenin signaling pathway.
    Xia S; Ji R; Zhan W
    BMC Neurol; 2017 Feb; 17(1):30. PubMed ID: 28187755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NLRP3 in human glioma is correlated with increased WHO grade, and regulates cellular proliferation, apoptosis and metastasis via epithelial-mesenchymal transition and the PTEN/AKT signaling pathway.
    Yin XF; Zhang Q; Chen ZY; Wang HF; Li X; Wang HX; Li HX; Kang CM; Chu S; Li KF; Li Y; Qiu YR
    Int J Oncol; 2018 Sep; 53(3):973-986. PubMed ID: 30015880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel lncRNA, RPL34-AS1, promotes proliferation and angiogenesis in glioma by regulating VEGFA.
    Zhang D; Jiang H; Ye J; Gao M; Wang X; Lu E; Yang H; Wang L; Zhao S
    J Cancer; 2021; 12(20):6189-6197. PubMed ID: 34539892
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.